Bharat Biotech Initiates Clinical Trials of TB Vaccine on Adults

Leading vaccines & bio-therapeutics manufacturers, Bharat Biotech Global Ltd added that it began clinical preliminaries of the tuberculosis immunization Mtbvac on adults in India. This is the initial immunization against Tuberculosis from a human...

Dr Reddy's, Pharmazz Sign Licence Pact To Commercialise Novel Therapy

Leading pharmaceutical firm Dr. Reddy's Laboratories announced that it has signed a license agreement with US-based biopharma Pharmazz to commercialize the first-in-class breakthrough medication Centhaquine in India.  Centhaquine, developed by...

Social Media's Mental Health Impact: Safe Navigation in the Digital Age

In the current digital era, children and young adults have been immersed in technology since an early age. Computers, mobile devices, and the internet have become their constant companions.

WHO Releases New Guidelines for Drug Resistant TB Diagnosis

The World Health Organization (WHO) has recently published recommendations on the use of targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB).

Indian Businesses Lead CSR Health Projects: SoulAce Study

A recent study conducted by SoulAce, a consulting firm specializing in CSR (Corporate Social Responsibility) initiatives and monitoring & evaluation, reveals that Indian businesses have successfully spearheaded CSR health projects

Novo Nordisk Ventures Enters Healthium Medtech Race

Novo Holdings, which holds a controlling stake in Denmark's diabetes and obesity drug manufacturer, Novo Nordisk, is reportedly bidding for Healthium Medtech, India's leading producer of surgical sutures and surgical needles.

Cost-Effective Detection of Pharmaceutical Contaminants in Water

The escalation of pharmaceutical waste and contaminants has become a growing global concern, especially about drinking water and food safety.

IIT Madras Develops NeoStand Electric Standing Wheelchair

The Central Drugs Standard Control Organisation (CDSCO) has undertaken the digitization and streamlining of the regulatory submission process

Antengene Declares Preclinical Study Results on Bispecific Antibody

Antengene Corporation Limited declared that the consequences of its re-clinical examinations on ATG-101 (PD-L1/4-1BB bispecific immunizer) were distributed in Cancer Research in a paper named ATG-101 is a tetravalent PD-L1×4-1BB bispecific...

Portea Medical Hits 10 Million Appointments in 10-Year Healthcare Journey

Portea Medical, a prominent healthcare provider in India, has achieved a remarkable milestone by crossing 10 million appointments conducted at patients' homes over a decade.

© 2025 India Pharma Outlook. All Rights Reserved.